Cefepime Tazobactam Injection, Strength: 1.125 gm

Cefepime (1000mg) + Tazobactum (125mg) Injection combines cefepime and tazobactam, offering a powerful therapeutic option for treating a variety of serious bacterial infections. Cefepime, a fourth-generation cephalosporin antibiotic, exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. Tazobactam, a beta-lactamase inhibitor, enhances the efficacy of cefepime by preventing the breakdown of the antibiotic by resistant bacterial enzymes, thereby extending its spectrum of activity against resistant strains.

This formulation is particularly effective in treating conditions such as pneumonia, urinary tract infections, skin infections, and intra-abdominal infections caused by susceptible organisms. Due to its ability to penetrate well into tissues, Tillpime TZ is also utilized in the management of febrile neutropenia and other severe infections where rapid therapeutic intervention is critical.